Yoshiki Sugimura - Search Results

Year	Number of Results
2002	6
2003	13
2004	14
2005	5
2006	6
2007	12
2008	11
2009	11
2010	9
2011	12
2012	9
2013	12
2014	8
2015	5
2016	7
2017	5
2018	6
2019	8
2020	7
2021	5
2024	0

1

A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy.

Owa S, Sasaki T, Uchida K, Watanabe S, Kato M, Sugino Y, Kato M, Masui S, Nishikawa K, Yoshio Y, Kanda H, Sugimura Y, Inoue T. Owa S, et al. Among authors: sugimura y. IJU Case Rep. 2021 Jun 19;4(5):267-271. doi: 10.1002/iju5.12298. eCollection 2021 Sep. IJU Case Rep. 2021. PMID: 34497979 Free PMC article.

2

[Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].

Sugino Y, Nishikawa K, Kato M, Sasaki T, Kato M, Masui S, Yoshio Y, Kanda H, Sugimura Y, Inoue T. Sugino Y, et al. Among authors: sugimura y. Hinyokika Kiyo. 2021 Jul;67(7):303-308. doi: 10.14989/ActaUrolJap_67_7_303. Hinyokika Kiyo. 2021. PMID: 34353010 Free article. Japanese.

3

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer.

Sasaki T, Nishikawa K, Kato M, Masui S, Yoshio Y, Sugimura Y, Inoue T. Sasaki T, et al. Among authors: sugimura y. Med Sci (Basel). 2021 Apr 9;9(2):24. doi: 10.3390/medsci9020024. Med Sci (Basel). 2021. PMID: 33918590 Free PMC article.

4

Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts.

Ishii K, Nakagawa Y, Matsuda C, Katoh D, Ichishi M, Shirai T, Hirokawa Y, Fujiwara M, Sugimura Y, Watanabe M. Ishii K, et al. Among authors: sugimura y. J Cell Biochem. 2021 Jun;122(6):679-688. doi: 10.1002/jcb.29893. Epub 2021 Jan 22. J Cell Biochem. 2021. PMID: 33480080

5

[A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].

Owa S, Sasaki T, Ishihara M, Watanabe S, Kato M, Sugino Y, Kato M, Masui S, Nishikawa K, Yoshio Y, Kanda H, Sugimura Y, Inoue T. Owa S, et al. Among authors: sugimura y. Hinyokika Kiyo. 2020 Dec;66(12):449-452. doi: 10.14989/ActaUrolJap_66_12_449. Hinyokika Kiyo. 2020. PMID: 33435656 Free article. Japanese.

6

Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non-expressors early after living donor kidney transplantation: Effect of interleukin 6-induced suppression of the cytochrome P450 3A gene.

Enokiya T, Nishikawa K, Hamada Y, Ikemura K, Sugimura Y, Okuda M. Enokiya T, et al. Among authors: sugimura y. Basic Clin Pharmacol Toxicol. 2021 Mar;128(3):525-533. doi: 10.1111/bcpt.13539. Epub 2020 Dec 12. Basic Clin Pharmacol Toxicol. 2021. PMID: 33248001 Free article.

7

A Kidney Transplant Recipient with Recurrent Henoch-Schönlein Purpura Nephritis Successfully Treated with Steroid Pulse Therapy and Epipharyngeal Abrasive Therapy.

Fujimoto M, Katayama K, Nishikawa K, Mizoguchi S, Oda K, Hirabayashi Y, Suzuki Y, Haruki A, Ito T, Murata T, Ishikawa E, Sugimura Y, Ito M. Fujimoto M, et al. Among authors: sugimura y. Nephron. 2020;144 Suppl 1:54-58. doi: 10.1159/000511166. Epub 2020 Nov 20. Nephron. 2020. PMID: 33221802 Free article.

8

[Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma].

Nishikawa T, Sugino Y, Owa S, Kitano G, Sasaki T, Kato M, Masui S, Nishikawa K, Yoshio Y, Kanda H, Arima K, Sugimura Y, Uchida K. Nishikawa T, et al. Among authors: sugimura y. Hinyokika Kiyo. 2020 Apr;66(4):115-119. doi: 10.14989/ActaUrolJap_66_4_115. Hinyokika Kiyo. 2020. PMID: 32483945 Free article. Japanese.

9

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

Ishihara M, Tono Y, Miyahara Y, Muraoka D, Harada N, Kageyama S, Sasaki T, Hori Y, Soga N, Uchida K, Shiraishi T, Sato E, Kanda H, Mizuno T, Webster GA, Ikeda H, Katayama N, Sugimura Y, Shiku H. Ishihara M, et al. Among authors: sugimura y. Cancer Immunol Immunother. 2020 Apr;69(4):663-675. doi: 10.1007/s00262-020-02483-1. Epub 2020 Jan 24. Cancer Immunol Immunother. 2020. PMID: 31980914 Free PMC article. Clinical Trial.

10

Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure.

Kajiwara S, Ishii K, Sasaki T, Kato M, Nishikawa K, Kanda H, Arima K, Watanabe M, Sugimura Y. Kajiwara S, et al. Among authors: sugimura y. Lab Invest. 2020 May;100(5):670-681. doi: 10.1038/s41374-019-0352-4. Epub 2019 Dec 19. Lab Invest. 2020. PMID: 31857695 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year